Impact of Vertebral Fractures and Glucocorticoid Exposure on Height Deficits in Children During Treatment of Leukemia

scientific article published on 01 February 2019

Impact of Vertebral Fractures and Glucocorticoid Exposure on Height Deficits in Children During Treatment of Leukemia is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1210/JC.2018-01083
P932PMC publication ID6291659
P698PubMed publication ID30247635

P50authorDavid MoherQ28036061
Sara IsraelsQ37830707
David DixQ47015135
Conrad V FernandezQ90710197
P2093author name stringRonald Barr
Robert Stein
Frank Rauch
Jacob L Jaremko
Jacqueline Halton
Anne Marie Sbrocchi
Brian Lentle
Celia Rodd
Elizabeth A Cummings
Jinhui Ma
Josephine Ho
Kerry Siminoski
Leanne M Ward
Mary Ann Matzinger
Nathalie Alos
Nazih Shenouda
Robert Couch
Stephanie Atkinson
David Stephure
Ronald M Grant
Sharon Abish
Caroline Laverdière
Beverly Wilson
Victor A Lewis
Elizabeth Cairney
Canadian STOPP Consortium
P2860cites workStature and Status: Height, Ability, and Labor Market OutcomesQ24650002
A Modeling Capacity of Vertebral Fractures Exists During Growth—an up to 47-Year Follow-upQ33193123
High incidence of vertebral fractures in children with acute lymphoblastic leukemia 12 months after the initiation of therapyQ33618291
Disproportionate short stature after cranial irradiation and combination chemotherapy for leukaemiaQ33624689
Risk of late effects of treatment in children newly diagnosed with standard-risk acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study cohortQ34079996
The epidemiology of corticosteroid-induced osteoporosis: a meta-analysisQ34961416
Effects of glucocorticoids on the growth plateQ36243092
Adult height, nutrition, and population healthQ36966803
Incident Vertebral Fractures in Children With Leukemia During the Four Years Following DiagnosisQ37008693
Height deficit during and many years after treatment for acute lymphoblastic leukemia in children: a review.Q37026832
Longitudinal assessment of bone density and structure in an incident cohort of children with Crohn's diseaseQ37250448
Advanced vertebral fracture among newly diagnosed children with acute lymphoblastic leukemia: results of the Canadian Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) research programQ37473111
Glucocorticoid Signaling and Bone BiologyQ39015604
Incremental growth tables: supplementary to previously published chartsQ41353474
Effect of glucocorticoids on growth and bone mineral density in children with nephrotic syndrome.Q41602217
Growth in children treated for acute lymphoblastic leukaemiaQ42102014
Height deficit and impairment of the GH/IGF-1 axis in patients treated for acute lymphoblastic leukemia during childhoodQ43796012
Accuracy of height loss during prospective monitoring for detection of incident vertebral fractures.Q45017082
Commentary: the long and short of why taller people are healthier and live longerQ45041647
Vertebral fracture assessment using a semiquantitative technique.Q45969757
Spinal deformity index (SDI) is a good predictor of incident vertebral fracturesQ46167288
Longitudinal linear growth and final height is impaired in childhood acute lymphoblastic leukemia survivors after treatment without cranial irradiationQ47258508
Normal final height after treatment for acute lymphoblastic leukemia without irradiationQ47365992
Longitudinal growth and final height in long-term survivors of childhood leukaemiaQ47369063
The accuracy of historical height loss for the detection of vertebral fractures in postmenopausal womenQ47369734
Final attained height in patients successfully treated for childhood acute lymphoblastic leukemiaQ47386574
Final height after treatment for childhood acute lymphoblastic leukemia: comparison of no cranial irradiation with 1800 and 2400 centigrays of cranial irradiationQ47391535
Reduction of adult height in childhood acute lymphoblastic leukemia survivors after prophylactic cranial irradiationQ47391629
Animal models to explore the effects of glucocorticoids on skeletal growth and structureQ50099531
The Spectrum of Recovery From Fracture-Induced Vertebral Deformity in Pediatric Leukemia.Q52884749
Centers for Disease Control and Prevention 2000 Growth Charts for the United States: Improvements to the 1977 National Center for Health Statistics VersionQ57196021
Population-based assessment of adverse events associated with long-term glucocorticoid useQ58974723
Bone Morbidity and Recovery in Children With Acute Lymphoblastic Leukemia: Results of a Six-Year Prospective Cohort StudyQ59960141
Growth in children treated for acute lymphoblastic leukemia with and without prophylactic cranial irradiationQ67986757
Growth and body composition in response to chemotherapy in children with acute lymphoblastic leukemiaQ77756350
Longitudinal growth and risk factors for growth deficiency in children treated for acute lymphoblastic leukemiaQ83340964
P433issue2
P304page(s)213-222
P577publication date2019-02-01
P1433published inThe Journal of Clinical Endocrinology and MetabolismQ3186902
P1476titleImpact of Vertebral Fractures and Glucocorticoid Exposure on Height Deficits in Children During Treatment of Leukemia
P478volume104